NHLBI Funding & Research Opportunities and Announcements for April 12, 2019

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

 

Notices

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Southern Regional Workshop on Sexual and Gender Minority (SGM)-Related Research (NOT-OD-19-097) National Institutes of Health

Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements

(NOT-OD-19-098) National Institutes of Health

Notice of Change to Eligibility Information and Key Dates in RFA-HL-20-009 "BLOODSAFE (UG3/UH3 Clinical Trial Optional)" and Announcement of Availability of FAQs

(NOT-HL-19-691) National Heart, Lung, and Blood Institute

Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-003: "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)

(NOT-HL-19-692) National Heart, Lung, and Blood Institute

Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-004 "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Research Coordinating Center (U24)"

(NOT-HL-19-693) National Heart, Lung, and Blood Institute

Notice of Change to Key Dates in RFA-HL-20-010 "BLOODSAFE (U24 Clinical Trial Not Allowed)"

(NOT-HL-19-694) National Heart, Lung, and Blood Institute

Requests for Applications

Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 Clinical Trial Optional)

(RFA-HL-20-005) National Heart, Lung, and Blood Institute